Reply to 'Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients'

AIDS. 2011 Apr 24;25(7):1012-3; author reply 1011-2. doi: 10.1097/QAD.0b013e3283463c84.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Darunavir
  • Drug Therapy, Combination / methods
  • HIV Infections / drug therapy
  • HIV Infections / metabolism*
  • HIV Protease Inhibitors / administration & dosage
  • HIV Protease Inhibitors / pharmacokinetics*
  • HIV-1*
  • Humans
  • Nitriles
  • Pyridazines / administration & dosage
  • Pyridazines / pharmacokinetics
  • Pyrimidines
  • Pyrrolidinones / administration & dosage
  • Pyrrolidinones / pharmacokinetics
  • Raltegravir Potassium
  • Ritonavir / administration & dosage
  • Ritonavir / pharmacokinetics
  • Sulfonamides / administration & dosage
  • Sulfonamides / pharmacokinetics

Substances

  • HIV Protease Inhibitors
  • Nitriles
  • Pyridazines
  • Pyrimidines
  • Pyrrolidinones
  • Sulfonamides
  • etravirine
  • Raltegravir Potassium
  • Ritonavir
  • Darunavir